MCID: BRN035
MIFTS: 37

Brain Stem Glioma malady

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Brain Stem Glioma

Aliases & Descriptions for Brain Stem Glioma:

Name: Brain Stem Glioma 12 14
Brainstem Neuroglial Tumor 12
Glioma of Brainstem 69

Classifications:



External Ids:

Disease Ontology 12 DOID:4202
NCIt 47 C8501
SNOMED-CT 64 444545003
UMLS 69 C0677865

Summaries for Brain Stem Glioma

MalaCards based summary : Brain Stem Glioma, also known as brainstem neuroglial tumor, is related to childhood brain stem glioma and adult brain stem glioma. An important gene associated with Brain Stem Glioma is EGFR (Epidermal Growth Factor Receptor), and among its related pathways/superpathways are MicroRNAs in cancer and Photodynamic therapy-induced AP-1 survival signaling.. The drugs Vincristine and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include brain and spinal cord.

Wikipedia : 71 A brainstem glioma is a cancerous glioma tumor in the brainstem. Around 75% are diagnosed in children... more...

Related Diseases for Brain Stem Glioma

Diseases in the Brain Stem Glioma family:

Adult Brain Stem Glioma

Diseases related to Brain Stem Glioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 44)
id Related Disease Score Top Affiliating Genes
1 childhood brain stem glioma 12.5
2 adult brain stem glioma 12.1
3 glioma 10.5
4 hyperbilirubinemia, familial transient neonatal 10.2 UGT1A UGT1A1
5 wolffian adnexal neoplasm 10.2 EGFR TP53
6 paternal uniparental disomy of chromosome 1 10.2 EGFR TP53
7 childhood embryonal testis carcinoma 10.2 EGFR TP53
8 exudative glomerulonephritis 10.2 EGFR TP53
9 ovarian embryonal carcinoma 10.2 EGFR TP53
10 parathyroid transitional clear cell adenoma 10.2 EGFR PDGFB
11 spastic paraplegia 1 10.2 EGFR TP53
12 chronic monocytic leukemia 10.2 EGFR TP53
13 reactive arthritis 10.2 EGFR TP53
14 ossifying fibromyxoid tumor 10.2 TP53 UGT1A1
15 thymus squamous cell carcinoma 10.2 EGFR TP53
16 crigler-najjar syndrome, type ii 10.2 UGT1A UGT1A1
17 secondary hyperparathyroidism of renal origin 10.1 EGFR TP53
18 cutaneous adenocystic carcinoma 10.1 BSG TP53
19 abacavir toxicity 10.1 EGFR UGT1A UGT1A1
20 multicentric papillary thyroid carcinoma 10.1 EGFR TP53
21 fallopian tube benign neoplasm 10.1 EGFR TP53
22 his bundle tachycardia 10.1 EGFR TP53
23 mediastinum synovial sarcoma 10.0 PDGFB TP53
24 non-distal monosomy 10q 10.0 BSG EGFR TP53
25 childhood brain germinoma 10.0 BSG TP53
26 ladd syndrome 10.0 BSG EGFR TP53
27 immunodeficiency due to a late component of complement deficiency 10.0 EGFR TP53
28 adult oligodendroglioma 10.0 EGFR PDGFB TP53
29 glucosephosphate isomerase deficiency 10.0 EGFR PDGFB TP53
30 myxedema 9.9 EGFR TP53
31 gastroesophageal reflux 9.7
32 neurofibromatosis, type 1 9.7
33 moyamoya disease 9.7
34 hydrocephalus 9.7
35 thrombosis 9.7
36 meningoencephalitis 9.7
37 panniculitis 9.7
38 demyelinating disease 9.7
39 neurofibromatosis 9.7
40 encephalitis 9.7
41 diffuse intrinsic pontine glioma 9.7
42 dysphagia 9.7
43 hair disease 9.2 BSG MYLIP PDGFB SNORD13 TMPRSS11D TP53
44 brainstem intraparenchymal clear cell meningioma 8.8 BSG EGFR MYLIP PDGFB SNORD13 TMPRSS11D

Graphical network of the top 20 diseases related to Brain Stem Glioma:



Diseases related to Brain Stem Glioma

Symptoms & Phenotypes for Brain Stem Glioma

Drugs & Therapeutics for Brain Stem Glioma

Drugs for Brain Stem Glioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 308)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
2
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
3
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
4
Methotrexate Approved Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
5
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
6
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
7
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
8
Ifosfamide Approved Phase 3,Phase 1,Phase 2 3778-73-2 3690
9
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
10
Dacarbazine Approved, Investigational Phase 2, Phase 3, Phase 1, Early Phase 1 4342-03-4 5351166
11
Temozolomide Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 85622-93-1 5394
12
Thiotepa Approved Phase 3,Phase 2,Phase 1 52-24-4 5453
13
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
14
Lomustine Approved Phase 3,Phase 2,Phase 1 13010-47-4 3950
15
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
16
Levoleucovorin Approved Phase 3,Phase 1 68538-85-2
17
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
18
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
19
Histamine Approved, Investigational Phase 3,Phase 2 75614-87-8, 51-45-6 774
20
Cyproheptadine Approved Phase 3,Phase 2 129-03-3 2913
21
Procarbazine Approved Phase 3,Phase 2,Phase 1 671-16-9 4915
22
Isotretinoin Approved Phase 3,Phase 2 4759-48-2 5538 5282379
23
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
24
Thioguanine Approved Phase 3 154-42-7 2723601
25
Vorinostat Approved, Investigational Phase 2, Phase 3,Phase 1 149647-78-9 5311
26
Bevacizumab Approved, Investigational Phase 2, Phase 3,Phase 1,Early Phase 1 216974-75-3
27
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
28
Ondansetron Approved Phase 3 99614-02-5 4595
29
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
30
Meloxicam Approved, Vet_approved Phase 2, Phase 3 71125-38-7 5281106 54677470
31
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
32
leucovorin Approved, Nutraceutical Phase 3,Phase 2,Phase 1 58-05-9 54575, 6560146 143
33
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1 59-30-3 6037
34
Tretinoin Approved, Investigational, Nutraceutical Phase 3,Phase 2 302-79-4 5538
35 Alkylating Agents Phase 3,Phase 2,Phase 1,Early Phase 1
36 glucocorticoids Phase 3,Phase 1
37 Adjuvants, Immunologic Phase 3,Phase 2,Phase 1
38 Folic Acid Antagonists Phase 3,Phase 2,Phase 1
39 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Early Phase 1
40 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1
41 Dermatologic Agents Phase 3,Phase 2,Phase 1
42 Hormone Antagonists Phase 3,Phase 2,Phase 1
43 Hormones Phase 3,Phase 2,Phase 1
44 Vaccines Phase 2, Phase 3,Phase 1
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
46 Vitamin B Complex Phase 3,Phase 2,Phase 1
47 Etoposide phosphate Phase 3,Phase 2,Phase 1
48 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
49 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
50 Isophosphamide mustard Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 247)
id Name Status NCT ID Phase
1 Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas Unknown status NCT00278278 Phase 3
2 Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Unknown status NCT00392886 Phase 3
3 Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors Unknown status NCT00179803 Phase 2, Phase 3
4 Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children Completed NCT01635140 Phase 3
5 Combination Chemotherapy in Treating Children With Progressive Brain Tumors Completed NCT00002944 Phase 3
6 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3
7 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
8 High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Completed NCT00078988 Phase 3
9 Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children Recruiting NCT01878266 Phase 3
10 Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma Active, not recruiting NCT01236560 Phase 2, Phase 3
11 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Active, not recruiting NCT01346267 Phase 3
12 Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Active, not recruiting NCT00085202 Phase 3
13 Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children Active, not recruiting NCT00749723 Phase 2, Phase 3
14 Proteome-based Personalized Immunotherapy of Glioblastoma Enrolling by invitation NCT01759810 Phase 2, Phase 3
15 Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma Not yet recruiting NCT02864888 Phase 3
16 Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma Not yet recruiting NCT02887040 Phase 3
17 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3
18 Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors Terminated NCT00031798 Phase 3
19 Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma Unknown status NCT00024336 Phase 2
20 Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma Unknown status NCT00514397 Phase 2
21 A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain Unknown status NCT01403311 Phase 2
22 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors Unknown status NCT00281905 Phase 2
23 Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma Unknown status NCT01026493 Phase 1, Phase 2
24 Study of DC Vaccination Against Glioblastoma Unknown status NCT01567202 Phase 2
25 Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma Unknown status NCT01235845 Phase 1, Phase 2
26 High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood Unknown status NCT00180791 Phase 2
27 Antineoplaston Therapy in Treating Patients With Brain Stem Glioma Completed NCT00003459 Phase 2
28 Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma Completed NCT00179881 Phase 2
29 A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas Completed NCT01118377 Phase 2
30 Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma Completed NCT00079339 Phase 1, Phase 2
31 Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma Completed NCT00070525 Phase 2
32 Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma Completed NCT01145170 Phase 2
33 Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma Completed NCT00381797 Phase 2
34 ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors Completed NCT01756989 Phase 2
35 Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma Completed NCT00387790 Phase 2
36 Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas Completed NCT00042991 Phase 1, Phase 2
37 O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors Completed NCT00275002 Phase 2
38 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2
39 Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma Completed NCT00028795 Phase 2
40 Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors Completed NCT00002619 Phase 2
41 A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas Completed NCT00036569 Phase 2
42 Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma Completed NCT00003616 Phase 1, Phase 2
43 Irinotecan in Treating Patients With Recurrent Glioma Completed NCT00003134 Phase 2
44 Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor Completed NCT00004068 Phase 2
45 Carboplatin in Patients With Progressive Gliomas Completed NCT00002749 Phase 2
46 Temozolomide in Treating Patients With Progressive Low-Grade Glioma Completed NCT00003466 Phase 2
47 Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas Completed NCT01574092 Phase 2
48 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2
49 Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer Completed NCT00014573 Phase 2
50 Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors Completed NCT00095940 Phase 1, Phase 2

Search NIH Clinical Center for Brain Stem Glioma

Genetic Tests for Brain Stem Glioma

Anatomical Context for Brain Stem Glioma

MalaCards organs/tissues related to Brain Stem Glioma:

39
Brain, Spinal Cord

Publications for Brain Stem Glioma

Articles related to Brain Stem Glioma:

(show top 50) (show all 56)
id Title Authors Year
1
Brain stem glioma with spinal cord involvement in a young with neurofibromatosis type 1. ( 24614250 )
2014
2
Intracranial syphilitic gumma mimicking a brain stem glioma. ( 22723064 )
2012
3
Treatment of progressive brain stem glioma with bevacizumab: radiological, metabolic and histopathological aspects. ( 22048887 )
2012
4
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. ( 21233173 )
2011
5
Shall we treat hydrocephalus associated to brain stem glioma in children? ( 21928037 )
2011
6
Diffuse brain stem glioma. ( 20212241 )
2010
7
DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma. ( 20363335 )
2010
8
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study. ( 17278121 )
2008
9
Brain stem glioma, a rare cause of hearing loss and dysequilibrium. ( 21063295 )
2008
10
Commentary on diffuse brain stem glioma in children. ( 19016114 )
2008
11
Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas. ( 18324354 )
2008
12
HSV encephalitis in a child with brain stem glioma: a rare complication of therapy. Case report and review of the neurosurgical literature. ( 17593375 )
2007
13
Somatostatin-receptor positive brain stem glioma visualized by octreoscan. ( 17627256 )
2007
14
Brain stem glioma: two case studies. ( 15695354 )
2005
15
Irinotecan therapy in a 12-year-old girl with recurrent brain stem glioma and without functional polymorphisms in UGT1A1 activity: case report. ( 16187025 )
2005
16
Biopsy of brain stem glioma using motor-evoked potential mapping by direct peduncular stimulation and individual adjuvant therapy. Case report. ( 15699622 )
2005
17
Recurrent haemorrhage from a malignant brain stem glioma: a review of the mechanisms of tumoural haemorrhage. ( 12948477 )
2003
18
Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report. ( 12718563 )
2003
19
Brain stem glioma in a child: false diagnosis of radiation necrosis with FDG PET. ( 12555260 )
2003
20
ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. ( 14506149 )
2003
21
Childhood Brain Stem Glioma Treatment (PDQAr): Health Professional Version ( 27010061 )
2002
22
Childhood Brain Stem Glioma Treatment (PDQAr): Health Professional Version ( 26389253 )
2002
23
Childhood Brain Stem Glioma Treatment (PDQAr): Patient Version ( 27227262 )
2002
24
Childhood Brain Stem Glioma Treatment (PDQAr): Health Professional Version ( 27227258 )
2002
25
Childhood Brain Stem Glioma Treatment (PDQAr): Patient Version ( 26389295 )
2002
26
Moyamoya disease associated with a brain stem glioma. ( 10855525 )
2000
27
Brain stem glioma--a study of 111 patients. ( 10921213 )
1999
28
Clinical management of brain stem glioma. ( 10332008 )
1999
29
Diffuse brain stem glioma. A review of stereotactic biopsies. ( 10392494 )
1999
30
Neuroimaging of pediatric brain stem diseases other than brain stem glioma. ( 9075252 )
1996
31
Leptomyxid amebic meningoencephalitis mimicking brain stem glioma. ( 7611076 )
1995
32
Bilateral jawline nodules in a child with a brain-stem glioma. Poststeroid panniculitis. ( 7492138 )
1995
33
Intra-arterial chemotherapy for brain stem glioma: report of four cases. ( 8108006 )
1994
34
Quality of survival among children treated for brain stem glioma. ( 8043460 )
1994
35
Brain-stem glioma growth patterns. ( 8433142 )
1993
36
Pathological laughter and brain stem glioma. ( 1640246 )
1992
37
Radiotherapy for pediatric brain stem glioma: radiation dose, response, and survival. ( 1407449 )
1992
38
Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. ( 1902547 )
1991
39
Brain stem glioma: the role of a biopsy. ( 1892569 )
1991
40
Prolonged response to carboplatin in an infant with brain stem glioma. ( 1985722 )
1991
41
Nursing care of the child with a brain stem glioma. ( 2254841 )
1990
42
A case of dyschondroplasia associated with brain stem glioma: diagnosis by stereotactic biopsy. ( 2234348 )
1990
43
Chronic dysphagia, vomiting and gastroesophageal reflux as manifestations of a brain stem glioma: a case report. ( 2488955 )
1989
44
Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial. ( 2709109 )
1989
45
Transient late magnetic resonance imaging changes suggesting progression of brain stem glioma: implications for entry criteria for phase II trials. ( 3054620 )
1988
46
Brain stem glioma mimicking progressive basilar artery thrombosis. ( 2834522 )
1988
47
Brain stem glioma presenting as gastro-oesophageal reflux. ( 3632023 )
1987
48
Orthostatic hypotension with lower brain stem glioma. ( 7161610 )
1982
49
Brain stem glioma in childhood: acute hemiplegic onset. ( 6269714 )
1981
50
Brain stem glioma complicated by Strongyloides stercoralis. ( 7325594 )
1981

Variations for Brain Stem Glioma

Expression for Brain Stem Glioma

Search GEO for disease gene expression data for Brain Stem Glioma.

Pathways for Brain Stem Glioma

Pathways related to Brain Stem Glioma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.91 EGFR PDGFB TP53
2 11.03 EGFR TP53
3 10.84 EGFR UGT1A1
4 10.84 EGFR PDGFB TP53
5 10.47 EGFR TP53

GO Terms for Brain Stem Glioma

Biological processes related to Brain Stem Glioma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of fibroblast proliferation GO:0048146 9.4 EGFR PDGFB
2 positive regulation of DNA replication GO:0045740 9.37 EGFR PDGFB
3 cellular response to estradiol stimulus GO:0071392 9.32 EGFR UGT1A1
4 positive regulation of reactive oxygen species metabolic process GO:2000379 9.26 PDGFB TP53
5 embryonic placenta development GO:0001892 9.16 EGFR PDGFB
6 positive regulation of pri-miRNA transcription from RNA polymerase II promoter GO:1902895 8.96 PDGFB TP53
7 phosphatidylinositol-mediated signaling GO:0048015 8.8 EGFR PDGFB TP53

Molecular functions related to Brain Stem Glioma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein heterodimerization activity GO:0046982 8.92 EGFR PDGFB TP53 UGT1A1

Sources for Brain Stem Glioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....